110 related articles for article (PubMed ID: 22153939)
1. Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens.
Kumar R; Rathy S; Hajare AK; Surase YB; Dullu J; Jadhav JS; Venkataramanan R; Chakrabarti A; Pandya M; Bhateja P; Ramkumar G; Das B
Bioorg Med Chem Lett; 2012 Jan; 22(1):476-81. PubMed ID: 22153939
[TBL] [Abstract][Full Text] [Related]
2. Activity of a novel series of acylides active against community-acquired respiratory pathogens.
Pandya M; Chakrabarti A; Rathy S; Katoch R; Venkataraman R; Bhateja P; Mathur T; Kumar GR; Malhotra S; Rao M; Bhadauria T; Barman TK; Das B; Upadhyay D; Bhatnagar PK
Int J Antimicrob Agents; 2010 Aug; 36(2):169-74. PubMed ID: 20493666
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Xu P; Liu L; Chen XZ; Li Y; Liu J; Jin ZP; Wang GQ; Lei PS
Bioorg Med Chem Lett; 2009 Aug; 19(15):4079-83. PubMed ID: 19560350
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A
J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234
[TBL] [Abstract][Full Text] [Related]
5. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
Felmingham D
J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Guo H; Hu H; Zhou D; Hu X
Eur J Med Chem; 2010 Sep; 45(9):3636-44. PubMed ID: 20554083
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Sugimoto T; Shimazaki Y; Manaka A; Tanikawa T; Suzuki K; Nanaumi K; Kaneda Y; Yamasaki Y; Sugiyama H
Bioorg Med Chem Lett; 2012 Sep; 22(17):5739-43. PubMed ID: 22858102
[TBL] [Abstract][Full Text] [Related]
8. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
Pavlović D; Fajdetić A; Mutak S
Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides.
Beebe X; Yang F; Bui MH; Mitten MJ; Ma Z; Nilius AM; Djuric SW
Bioorg Med Chem Lett; 2004 May; 14(10):2417-21. PubMed ID: 15109624
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of novel 8a-aza-8a-homoerythromycin A ketolides.
Pavlović D; Mutak S
J Med Chem; 2010 Aug; 53(15):5868-80. PubMed ID: 20684614
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.
Ling TK; Lee CC
Chemotherapy; 2005 Jul; 51(4):182-5. PubMed ID: 15980628
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
Walsh F; Carnegy F; Willcock J; Amyes S
J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
[TBL] [Abstract][Full Text] [Related]
13. Will resistance to ketolides develop in Streptococcus pneumoniae?
Leclercq R
J Infect; 2002 Feb; 44 Suppl A():11-6. PubMed ID: 12150490
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
[TBL] [Abstract][Full Text] [Related]
16. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides.
Xu Y; Chen X; Zhu D; Liu Y; Zhao Z; Jin L; Liu C; Lei P
Eur J Med Chem; 2013 Nov; 69():174-81. PubMed ID: 24021890
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of novel C12 ethyl ketolides.
Burger MT; Hiebert C; Seid M; Chu DT; Barker L; Langhorne M; Shawar R; Kidney J; Desai MC; Plattner JJ
Bioorg Med Chem; 2006 Aug; 14(16):5592-604. PubMed ID: 16697203
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains.
Zhao ZH; Zhang XX; Jin LL; Yang S; Lei PS
Bioorg Med Chem Lett; 2018 Aug; 28(14):2358-2363. PubMed ID: 29937059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
